A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma

Clinical trial NCT00389051 · COMPLETED

Trial details

NCT number: NCT00389051
Sponsor: SymBio Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2006-10-31
Primary completion: 2007-07-05
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.